AMLODIPINE AND ATORVASTATIN and OEDEMA PERIPHERAL

Overview

OEDEMA PERIPHERAL is the #12 most commonly reported adverse reaction for AMLODIPINE AND ATORVASTATIN, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 117 FDA adverse event reports linking AMLODIPINE AND ATORVASTATIN to OEDEMA PERIPHERAL. This represents approximately 1.8% of all 6,537 adverse event reports for this drug.

Patients taking AMLODIPINE AND ATORVASTATIN who experience oedema peripheral should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

OEDEMA PERIPHERAL is a less commonly reported adverse event for AMLODIPINE AND ATORVASTATIN, but still significant enough to appear in the safety profile.

Other Side Effects of AMLODIPINE AND ATORVASTATIN

In addition to oedema peripheral, the following adverse reactions have been reported for AMLODIPINE AND ATORVASTATIN:

• DIZZINESS — 181 reports
• NAUSEA — 175 reports
• DRUG INEFFECTIVE — 174 reports
• FATIGUE — 167 reports
• MALAISE — 161 reports
• PAIN — 143 reports
• DYSPNOEA — 141 reports
• DEATH — 137 reports
• HYPERTENSION — 129 reports
• HEADACHE — 127 reports

Other Drugs Associated with OEDEMA PERIPHERAL

The following drugs have also been linked to oedema peripheral in FDA adverse event reports:

Does AMLODIPINE AND ATORVASTATIN cause OEDEMA PERIPHERAL?

OEDEMA PERIPHERAL has been reported as an adverse event in 117 FDA reports for AMLODIPINE AND ATORVASTATIN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is OEDEMA PERIPHERAL with AMLODIPINE AND ATORVASTATIN?

OEDEMA PERIPHERAL accounts for approximately 1.8% of all adverse event reports for AMLODIPINE AND ATORVASTATIN, making it a notable side effect.

What should I do if I experience OEDEMA PERIPHERAL while taking AMLODIPINE AND ATORVASTATIN?

If you experience oedema peripheral while taking AMLODIPINE AND ATORVASTATIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages